Some data on trials for FDA-approved cancer drugs 'unavailable to independent scrutiny

Healio
Jul 28, 2022

Some data on trials for FDA-approved cancer drugs 'unavailable to independent scrutiny


Although efforts have been made to increase sharing of individual participant data from clinical trials, data from many oncology clinical trials that support FDA approval of anticancer therapies remain unavailable to researchers.

The findings, published in JAMA Oncology, suggest data accessibility could be improved if all data that support the FDA registration of treatment became available at the time of FDA approval, researchers noted.